Avisi Technologies, an ophthalmic medical device company advancing novel, sight-saving technologies, announces the closing of $10.7M in new financing. The Series A round was led by MedVenture Partners, with participation from new investors Sherpa Healthcare Partners, SNBL-Gemseki, SBI US Gateway Fund, Golden Seeds, and OneOneFive.

Avisi Technologies是一家致力于研发新型视力保护技术的眼科医疗器械公司，宣布完成了1070万美元的新一轮融资。本轮融资由MedVenture Partners领投，新投资者包括Sherpa Healthcare Partners、SNBL-Gemseki、SBI美国门户基金、Golden Seeds和OneOneFive参与。

This financing round had strong participation from existing investors, including Good Growth Capital, Accanto Partners, Life Sciences Greenhouse Investment, and Quaker Capital Investments..

本轮融资获得了现有投资者的大力支持，包括 Good Growth Capital、Accanto Partners、Life Sciences Greenhouse Investment 和 Quaker Capital Investments。